KRAS and cancer: Members of the rat sarcoma (RAS) oncogene family, including Kirsten-RAS (KRAS), Harvey-RAS (HRAS), and neuroblastoma-RAS (NRAS), exhibit the highest mutation frequency in human cancers, with associated mutations being identified in approximately 30% of all cancers [15].